معرفی
Pål Andre Holme is a Professor II in the Department of Haematology at the University of Oslo. His primary affiliation is with Oslo University Hospital Rikshospitalet, where he contributes to clinical and research activities in haemostasis and thrombosis. His work focuses on haemophilia management, inhibitor treatment, and clinical outcomes in bleeding disorders.
Research interests include prophylactic therapies for haemophilia A/B, management of antithrombotic therapy in bleeding disorder patients, and real-world data analysis of bypassing agents. He has co-authored studies on extended half-life factor therapies, antibody responses, and health equity in haemophilia care.
Recent articles emphasize clinical trials of novel coagulation factors, inhibitor management strategies, and the impact of socioeconomic factors on haemophilia treatment. Collaborative projects with Nordic institutions highlight his regional influence in haemophilia research.
